Growth hormone treatment during hemodialysis in a randomized trial improves nutrition, quality of life, and cardiovascular risk

Growth hormone treatment during hemodialysis in a randomized trial improves nutrition, quality of life, and cardiovascular risk

10.1681/ASN.2006111207

Saved in:
Bibliographic Details
Main Authors: Feldt-Rasmussen, B., Lange, M., Sulowicz, W., Gafter, U., Kar, N.L., Wiedemann, J., Christiansen, J.S., El Nahas, M., Sulkova, S., Madsen, M., Hannedouche, T., Lai, K.N., Holtzman, E., Schwartz, D., Katzir, Z., Weissgarten, J., Majdan, M., Niemczyk, S., Lee, K.O., Ahlmen, J., Mitra, S., Rodger, R.S.C., Tapson, J.S., Rustom, R., Ayub, W., Mikhail, A., Thomas, M.
Other Authors: MEDICINE
Format: Article
Published: 2016
Online Access:http://scholarbank.nus.edu.sg/handle/10635/132799
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore

Internet

http://scholarbank.nus.edu.sg/handle/10635/132799

Similar Items